Results 51 to 60 of about 4,911,045 (202)

A Survey of the Tardive Dyskinesia Induced by Antipsychotic Drugs in Patients with Schizophrenia [PDF]

Iranian Journal of Psychiatry, 2010
"nObjective: Tardive Dyskinesia (TD), is one of the important problems of the patients with schizophrenia. The emergence of these side effects depends on so many factors such as the patients' age and the duration of antipsychotic treatment.
Naser tabibi, Firouzeh Sajedi, Roshanak Vameghi, Farin Solemani, Ali Nazeri Astaneh, Sahel. Hemmati   +5 more
doaj   +2 more sources

The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat

Neurobiology of Disease, 2006
Intrastriatal transplants of embryonic ventral mesencephalon can cause dyskinesia in patients with Parkinson's disease (PD). We assessed the impact of transplant size on the development of graft-induced dyskinesia.
E.L. Lane, C. Winkler, P. Brundin, M.A. Cenci   +3 more
doaj   +1 more source

Striatal TRPV1 activation by acetaminophen ameliorates dopamine D2 receptor antagonist–induced orofacial dyskinesia

JCI Insight, 2021
Antipsychotics often cause tardive dyskinesia, an adverse symptom of involuntary hyperkinetic movements. Analysis of the US Food and Drug Administration Adverse Event Reporting System and JMDC insurance claims revealed that acetaminophen prevented the ...
Koki Nagaoka, Takuya Nagashima, Nozomi Asaoka, Hiroki Yamamoto, Chihiro Toda, Gen Kayanuma, Soni Siswanto, Yasuhiro Funahashi, Keisuke Kuroda, Kozo Kaibuchi, Yasuo Mori, Kazuki Nagayasu, Hisashi Shirakawa, Shuji Kaneko   +13 more
doaj   +1 more source

Rapamycin, by Inhibiting mTORC1 Signaling, Prevents the Loss of Striatal Bidirectional Synaptic Plasticity in a Rat Model of L-DOPA-Induced Dyskinesia

Frontiers in Aging Neuroscience, 2020
Levodopa (L-DOPA) treatment is the main gold-standard therapy for Parkinson disease (PD). Besides good antiparkinsonian effects, prolonged use of this drug is associated to the development of involuntary movements known as L-DOPA-induced dyskinesia (LID).
Valeria Calabrese, Valeria Calabrese, Anna Di Maio, Gioia Marino, Gioia Marino, Antonella Cardinale, Antonella Cardinale, Giuseppina Natale, Giuseppina Natale, Arianna De Rosa, Federica Campanelli, Federica Campanelli, Maria Mancini, Francesco Napolitano, Francesco Napolitano, Luigi Avallone, Paolo Calabresi, Paolo Calabresi, Alessandro Usiello, Alessandro Usiello, Veronica Ghiglieri, Veronica Ghiglieri, Barbara Picconi, Barbara Picconi   +23 more
doaj   +1 more source

Potential protective role of ACE-inhibitors and AT1 receptor blockers against levodopa-induced dyskinesias: a retrospective case-control study

Neural Regeneration Research, 2021
Growing evidence has highlighted that angiotensin-converting enzyme (ACE)-inhibitors (ACEi)/AT1 receptor blockers (ARBs) may influence the complex interplay between dopamine and the renin-angiotensin system in the nigrostriatal pathway, thus affecting ...
Elena Contaldi, Luca Magistrelli, Anna V Milner, Marco Cosentino, Franca Marino, Cristoforo Comi   +5 more
doaj   +1 more source

Material Collected From the Induced Seismicity State Task Force Meeting, Wednesday, April 16, 2014, Newman University, Wichita, Kansas

, 2014
Announcement -- Agenda -- Breakout Sessions: Questions and Responses -- An Ounce of Understanding is Worth a Pound of Cure / by Kyle E. Murray -- Induced Seismicity and the Oil and Gas Industry -- Overview of Kansas Earthquakes / Rick Miller, Shelby ...
Induced Seismicity State Task Force Meeting (2014 : Wichita, Kan.)
core   +1 more source

Methods for Trends in overdose and other drug-induced deaths in Australia, 2004-2023 [PDF]

The National Illicit Drug Indicators Project provides epidemiological data on trends over time in drug-related harms and forms part of the broader Drug Trends program.
Chrzanowska, Agata ; https://orcid.org/, Degenhardt, Louisa, Sutherland, Rachel ; https://orcid.org/, Man, Nicola, Peacock, Amy   +4 more
core   +1 more source

Electroconvulsive therapy for depression and oral dyskinesia in a patient who developed parkinsonism induced by valbenazine

PCN Reports
Background Tardive dyskinesia (TD) is a movement disorder related to long‐term antipsychotic use and characterized by involuntary repetitive movements that often affect the oral and facial muscles.
Yuhei Mori, Yuhei Suzuki, Akiko Sato, Risa Shishido, Yuri Kobayashi, Yuta Fukuchi, Shota Inada, Yuka Iwasaki, Riko Sato, Keitaro Takada, Naoki Morita, Itaru Miura   +11 more
doaj   +1 more source

Drug-induced tardive dyskinesia: A case report

European Psychiatry, 2016
IntroductionTardive dyskinesia (TD) is a serious medical condition that affects a significant proportion of patients treated with antipsychotic agents.ObjectiveTo report a patient who developed tardive dyskinesia after initiation of antipsychotic and antidepressant treatment.Case reportMiss H.
I. Abida, I. Baati, S. Omri, R. Sallemi, J. Masmoudi   +4 more
openaire   +1 more source

The 5-HT1A-receptor agonist flibanserin reduces drug-induced dyskinesia in RGS9-deficient mice.

, 2012
Drug-induced dyskinesia is a major complication of dopamine replacement therapy in advanced Parkinson's disease consisting of dystonia, chorea and athetosis.
Strecker, K;Adamaszek, M;Ohm, S;Wegner, F;Beck, J;Schwarz, J
core   +1 more source